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Summary
The mammalian gastrointestinal tract harbors a com-
plex ecosystem consisting of countless bacteria in
homeostasis with the host immune system. Shaped
by evolution, this partnership has potential for symbi-
otic benefit. However, the identities of bacterial mole-
cules mediating symbiosis remain undefined. Here
we show that, during colonization of animals with the
ubiquitous gut microorganism Bacteroides fragilis, a
bacterial polysaccharide (PSA) directs the cellular
and physical maturation of the developing immune
system. Comparison with germ-free animals reveals
that the immunomodulatory activities of PSA during
B. fragilis colonization include correcting systemic T
cell deficiencies and TH1/TH2 imbalances and directing
lymphoid organogenesis. A PSA mutant of B. fragilis
does not restore these immunologic functions. PSA
presented by intestinal dendritic cells activates CD4+
T cells and elicits appropriate cytokine production.
These findings provide a molecular basis for host-
bacterial symbiosis and reveal the archetypal mole-
cule of commensal bacteria that mediates develop-
ment of the host immune system.
Introduction
Immediately after a sterile birth, mammals are initiated
into an organized and lifelong process of colonization
by foreign organisms. Shaped by eons of evolution,
some host-bacterial associations have developed into
prosperous relationships creating diverse environments.
No better example exists in biology than the astound-
ing numbers of bacteria harbored by the lower gastroin-
testinal tract of mammals (Hooper et al., 1998). By
young adulthood, humans and other mammals are host
to w1012 viable bacteria per gram of colonic content,
consisting of 500–1000 microbial species and outnum-
bering host cells by 100-fold (Hooper and Gordon,*Correspondence: smazmanian@rics.bwh.harvard.edu (S.K.M.);
dennis_kasper@hms.harvard.edu (D.L.K.)2001). The magnitude of this interaction between com-
mensal bacteria and mammals must predictably exert
fundamental influences on the physiology of both. The
most impressive feature of this relationship may be that
the host not only tolerates but has evolved to require
colonization by commensal microorganisms for its own
development and health.
Autochthonous (indigenous) bacteria in the mamma-
lian gut have long been appreciated for potential bene-
fits to the host: provision of essential nutrients, me-
tabolism of indigestible compounds, defense against
colonization by opportunistic pathogens, and contribu-
tions to the development of the intestinal architecture
(Hooper et al., 2000; Hooper et al., 2002). How and, more
importantly, why does the immunocompetent gut envi-
ronment allow the presence of multitudinous foreign
organisms? Researchers have proposed that certain
commensal bacteria have evolved to aid in the host’s
health; several organisms are being studied for pro-
biotic (beneficial) potential (Guarner and Malagelada,
2003; Rastall, 2004). The “hygiene hypothesis” sug-
gests that the appropriate bacterial constitution of the
human microflora is a factor in protection from allergy
and asthma (Umetsu et al., 2002; Von Hertzen and
Haahtela, 2004). Investigations have shown that the in-
teractions of commensal bacteria with Toll-like recep-
tors are critical for intestinal homeostasis (Rakoff-
Nahoum et al., 2004). The intimate relationships between
commensal microorganisms and the host immune sys-
tem are increasingly evident (Macpherson and Harris,
2004; Noverr and Huffnagle, 2004).
The mammalian immune system is a dynamic and
remarkable organ. In recognizing, responding, and
adapting to countless foreign and self molecules, the
immune system is central to processes of health and
disease. CD4+ T cells, a major component of the im-
mune system, are required for vital aspects of proper
immune function, from reactions to infectious agents to
control of autoimmune reactions and cancers (Janeway
et al., 2001). Effector CD4+ T cells are of two general
subtypes, T helper 1 (TH1) and T helper 2 (TH2), each
carrying out distinct and opposing activities. The proper
balance between TH1 and TH2 immunologic responses
is critical to overall human and animal health (Neurath
et al., 2002; Sheikh and Strachan, 2004). A role for com-
mensal bacteria in establishing this equilibrium has
been postulated (Bowman and Holt, 2001; Rook and
Brunet, 2002). We investigated the molecular contribu-
tions of specific autochthonous organisms to the cellu-
lar development of the host immune system.
Bacteroides fragilis is a ubiquitous and important
Gram-negative anaerobe that colonizes the mammalian
lower gastrointestinal tract. Bacteroides species are
among the earliest-colonizing and most numerically
prominent constituents of the gut microflora (Kononen
et al., 1992). Although capsular polysaccharides are
common in many bacterial species, B. fragilis elabo-
rates an unprecedented eight distinct surface polysac-
charides (Krinos et al., 2001). Several of these polymers
have a novel zwitterionic structure, with both positive
Cell
108and negative charges in each repeating unit (Tzianabos c
Wet al., 1993). Zwitterionic polysaccharides (ZPSs) are
unique T cell-dependent antigens that specifically me- o
idiate the proliferation of CD4+ T cells in vitro (Brubaker
et al., 1999; Tzianabos and Kasper, 2002). Adoptive (
ttransfer experiments show that responses to polysac-
charide A (PSA), the most immunodominant ZPS of m
aB. fragilis, are conferred by CD4+ T cells, not by B cells
or other T cells (Tzianabos et al., 1999). We have de- c
fscribed the novel internalization and processing of PSA
within endosomes of antigen-presenting cells (APCs) o
a(Cobb et al., 2004). Subsequent presentation of pro-
cessed polysaccharide by major histocompatibility com- t
fplex class II (MHC II) molecules activates CD4+ T cells
and represents a previously undescribed pathway of s
mantigen presentation. Thus, ZPSs appear to have evolved
novel biological activities shaped by coevolution with
the host immune system. T
Herein we show that monocolonization of germ-free R
animals with B. fragilis is sufficient to correct several A
immunologic defects found in the absence of a bacte- i
rial microflora. The organism’s immunomodulatory ac- i
tivity requires production of PSA, which mediates host 2
immune-system development through specific cellular d
and molecular interactions. The significance of PSA’s s
role in immune homeostasis lies in its ability to mediate i
establishment of a proper TH1/TH2 balance for the host, c
a fundamental aspect of healthy immunologic function. o
B. fragilis PSA is the first identified member of a novel a
class of molecules, referred to here as “symbiosis fac- s
tors,” that mediate the beneficial relationship between s
bacteria and mammalian hosts during mutualism. w
t
cResults
u
pMonocolonization of Germ-free Animals
2with B. fragilis Results in CD4+ T Cell Expansion
1We investigated the effects of bacterial colonization on
eimmune maturation in animals, exploring the role of the
omicrobial flora in systemic T cell development. We used
cgerm-free mice: animals born and raised in sterile isola-
vtors devoid of microbes. Initially, spleens were har-
avested from both conventionally colonized and germ-
tfree mice and were analyzed for total CD4+ T cells by
gflow cytometry (FC). All groups of mice had similar sple-
snic total lymphocyte counts (average: 1 × 108). Consis-
tent with seminal observations of a positive immuno-
logic role of autochthonous bacteria (Dobber et al., P
L1992), the lymphocyte population purified from spleens
of conventional SPF (specific-pathogen-free) mice with C
ta diverse gut microflora contains a greater proportion
of CD4+ T cells than that of germ-free mice (Figure l
i1A). Previous studies have documented the beneficial
role of commensal bacteria in intestinal development m
l(Hooper, 2004). The observed alteration in CD4+ T cell
proportions of splenic lymphocytes highlights the pro- a
tfound effects of bacterial colonization of the gut on the
systemic immune response. f
fSPF mice harbor a diverse and complex microbial
flora. To stringently investigate the influence of specific a
sbacterial constituents of the gut flora on the host im-
mune system, we needed to colonize germ-free mice B
cwith a single bacterial species. This approach allows
“real-time” measurements of responses to bacterialolonization in animals with a naive immune system.
e chose the model microorganism B. fragilis because
f its prominence in the normal microbial gut flora and
ts production of known immunomodulatory molecules
Kononen et al., 1992; Tzianabos and Kasper, 2002). In
he absence of competing bacterial species, germ-free
ice monoassociated with B. fragilis strain NCTC 9343
re readily colonized to high levels (>1010 cfu/g of fe-
es; Figure 1B). Flow cytometry of splenic lymphocytes
rom these mice shows a nearly complete restoration
f CD4+ T cells to conventional proportions (Figures 1A
nd 1C). Thus, B. fragilis monocolonization is sufficient
o correct CD4+ T cell deficiency in spleens of germ-
ree mice. No other bacterial species alone has been
hown to correct lymphoid defects in germ-free ani-
als (Cash and Hooper, 2005).
he Immunomodulatory Effects of B. fragilis
equire Production of PSA
t least 2 of the 8 capsular polysaccharides of B. frag-
lis are ZPSs, a unique class of bacterial molecules with
mmunomodulatory properties (Tzianabos and Kasper,
002). We wondered whether PSA, the most immuno-
ominant and highly conserved ZPS, plays a role in
plenic T cell expansion during B. fragilis commensal-
sm. We used PSA-deficient B. fragilis PSA to mono-
olonize germ-free mice (Coyne et al., 2001). The level
f intestinal colonization by the mutant is indistinguish-
ble from that by the isogenic parent strain, as as-
essed by fecal cfu counts (Figure 1B). Examination of
plenic lymphocyte populations from mice colonized
ith B. fragilis lacking PSA but expressing all other an-
igens produced by this organism reveals an inability to
orrect CD4+ T cell deficiencies in germ-free mice (Fig-
re 1C). In pooled experiments (n = 4), the average pro-
ortions of CD4+ T cells were: conventional, 17.82% ±
.1%; B. fragilis, 18.05% ± 1.9%; B. fragilis PSA,
0.95% ± 2.3%; and germ-free, 11.15% ± 1.5%. The
ffects were specific to CD4+ T cells, as the proportions
f CD8+ T cells and CD19+ B cells from splenic lympho-
ytes (Figure 1D) are indistinguishable between con-
entional and either monocolonized or germ-free mice,
s previously observed (Pereira et al., 1986). Together,
hese results show that B. fragilis colonizing the gut of
erm-free mice requires PSA production to correct host
ystemic CD4+ T cell deficiencies during commensalism.
SA Production by B. fragilis Directs
ymphoid Organogenesis
ommensal bacteria have long been appreciated for
heir positive impact on development of gut-associated
ymphoid tissues (GALT, including Peyer’s patches) and
ntraepithelial lymphocytes (IELs) and production of
ucosal IgA (Hooper, 2004). We studied whether cellu-
ar immune maturation after bacterial colonization was
lso manifested in the morphological and ultrastruc-
ural development of peripheral lymphoid tissues. Germ-
ree animals have recently been reported to display de-
ects in splenic structural development (Macpherson
nd Harris, 2004). We examined histological sections of
pleens from germ-free mice colonized with wild-type
. fragilis or B. fragilis PSA. Spleens from mice mono-
olonized with B. fragilis appear normal, with well-formed lymphocyte zones appearing as defined folli-
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109Figure 1. Cellular and Physical Immune Maturation in Germ-free Mice Requires PSA Production during Intestinal B. fragilis Colonization
(A) FC analysis of α-CD4-stained splenic lymphocytes from conventionally colonized (CNV) and germ-free (GF) mice reveals depletion of
CD4+ T cells in the absence of colonizing microflora in the GI tract. Results are representative of four experiments with pools of 3 to 5 mice.
(B) Quantitation of fecal cfu during monocolonization of GF mice with wild-type B. fragilis or an isogenic mutant deficient in PSA production
(B. fragilis PSA) reveals equivalent counts of viable bacteria from fecal pellets. Inset: Immunoblot of bacterial extracts with α-PSA after SDS-
PAGE separation and electrotransfer to PVDF membranes shows the lack of PSA expression by B. fragilis PSA.
(C) FC of α-CD4-stained splenic lymphocytes from GF mice shows that intestinal monocolonization of mice with B. fragilis results in comple-
mentation of CD4+ T cells. In the presence of every other antigen produced during colonization with B. fragilis PSA, the absence of PSA
results in no increase in CD4+ T cell counts. Results are representative of >10 experiments with single or pools of 3 to 5 mice.
(D) FC of splenic lymphocytes from CNV and GF mice colonized with wild-type B. fragilis or B. fragilis PSA reveals no significant differences
in CD19+ B cells (upper panels) or CD8+ T cells (lower panels) in the CD4− fraction. Results are representative of four experiments with pools
of 3 to 5 mice.
(E) H&E-stained sections of spleens from CNV mice (right) and GF mice monocolonized with wild-type B. fragilis (left) and B. fragilis PSA
(center). White pulp containing lymphocytes appears as darker-staining follicular structures (arrows). The lack of large, well-defined follicles
in mice colonized with B. fragilis PSA is a measure of T cell depletion and reflects developmental defects in organogenesis. All images were
taken at the same magnification.cles (white pulp) similar to those in conventional mice
with a complete gut flora (Figure 1E). The interspersed
red pulp is densely packed with red blood cells and
neutrophils. Spleens from germ-free mice colonized
with B. fragilis PSA show gross anatomical depletion
of the lymphocyte zones similar to that in uncolonized
germ-free mice (Macpherson and Harris, 2004). Folli-
cles are smaller, less defined, and more fragmented
than in germ-free mice colonized with wild-type B. frag-
ilis or conventional mice (Figure 1E). The overall size
and shape of spleens from all groups are comparable.
This finding suggests a role for PSA specifically in lym-phocyte development. Thus, changes in CD4+ T cell
expansion that are mediated by PSA produced by in-
testinal bacteria are consistent with the correction of
physical and developmental defects in secondary lym-
phoid tissues. This observation reflects the importance
of the beneficial relationship between commensal mi-
croorganisms and host physiology.
Purified PSA Is Sufficient to Expand T Cells
in Germ-free and Conventional Animals
The inability of a PSA-deficient mutant to cause T cell
expansion shows that the activity of this immunomodu-
Cell
110Ilatory molecule is required during B. fragilis coloniza-
ttion. Using chromatography to purify PSA extracted
afrom the surface of B. fragilis, we investigated whether
cPSA alone is sufficient to counter the CD4+ T cell de-
2fects in germ-free mice. Purity was assessed by various
smethods, including H1-NMR, spectroscopy, and gel
aelectrophoresis. The preparation was devoid of con-
3tamination by protein, nucleic acid, and endotoxin
t(LPS). Uncolonized germ-free mice were treated intra-
fperitoneally with purified PSA and then assessed for
csplenic T cell expansion. We found that purified PSA
arestores CD4+ T cell proportions among splenic lym-
nphocytes in germ-free mice to conventional levels (Fig-
ure 2A).
To assess whether the route of administration to mice P
Pof various backgrounds affects PSA’s immunomodula-
tory properties, both conventionally colonized C57Bl/6 TT
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TFigure 2. Purified PSA Treatment Is Sufficient for Expansion of
CD4+ T Cells v
(A) FC of α-CD4-stained splenic lymphocytes from GF mice treated b
intraperitoneally with PSA or PBS reveals PSA-dependent restora- q
tion of CD4+ T cells. Results are representative of two experiments i
with pools of four mice.
u(B) FC shows that oral treatment of conventional C57Bl/6 and
nBALB/c mice with purified PSA (PSA) results in an increase in CD4+
aT cell proportion among splenic lymphocytes over controls (PBS).
Results are representative of four experiments with pools of 3 to a
5 mice. M
(C) FC shows that oral treatment of conventional mice with purified
PSA does not affect proportions of CD8+ T cells or CD19+ B cells
wamong the CD4− splenic lymphocyte population.
o
mand BALB/c mice received purified PSA intragastrically.his treatment recapitulates intestinal exposure of ani-
als to PSA during colonization. Oral treatment led to
specific increase of splenic CD4+ T cells in conven-
ional mice (Figure 2B), showing that PSA’s effect is not
xclusive to germ-free animals. CD8+ T cell and CD19+
cell ratios were unaffected by PSA (Figure 2C) as for-
erly shown (Figure 1D). We found that specific re-
ognition of purified PSA by host immune components
n the intestines results in splenic CD4+ T cell ex-
ansion.
SA Is Specifically Recognized by Dendritic Cells,
ith Consequent Cell Activation
ll CD4+ T cell reactions require instruction to T cells
y APCs (Kidd, 2003; Kapsenberg, 2003). PSA is recog-
ized by APCs and then presented to T cells in vitro
Kalka-Moll et al., 2002). The cellular mechanism of PSA
ecognition in the intestine and subsequent signaling to
xpand splenic T cells is unknown. To characterize the
PC responsible for PSA effects in animals, we fed
ice fluorescently labeled PSA by gavage and then re-
overed cells from mesenteric lymph nodes (MLNs). As
hown by flow cytometry, PSA specifically associates
ith CD11c+ dendritic cells (DCs; Figure 3A), and not
ith CD4+ T cells or CD19+ B cells (Figure 3A, data not
hown) in the MLNs. The notion of in vivo DC recogni-
ion of PSA appears appropriate, as DCs are the only
PCs known to sample luminal contents from the intes-
ine and migrate to lymph nodes to initiate T cell reac-
ions (Rescigno et al., 2001; Mowat, 2003). Consistent
ith this hypothesis, no PSA is recovered from spleens
f orally treated mice (data not shown) despite splenic
cell expansion. In addition, confocal microscopy re-
eals that PSA is internalized by primary-cultured
one-marrow-derived DCs (BMDCs) and is subse-
uently displayed on the cell surface (Figure 3B). Thus
t appears that DCs sample intestinal PSA by antigen
ptake and migrate only as far as the local lymph
odes. These results agree with those of Macpherson
nd Uhr (2004), who observed that commensal bacteria
re internalized by intestinal DCs that migrate to
LNs only.
We next assessed whether the association of PSA
ith BMDCs leads to cell activation and maturation, as
nly mature DCs can activate T cells. PSA-mediated
aturation of DCs is measured by upregulation of MHC
I among CD11c+ cells from 22% to 43% after PSA
reatment (Figure 3C), a process required for efficient
ntigen display to the receptor on CD4+ T cells (Ban-
hereau and Steinman, 1998; Thery and Amigorena,
001). Treatment also increases expression of the co-
timulatory molecules CD80 (B7.1) and CD86 (B7.2) in
dose-dependent manner (data not shown and Figure
D, respectively), a result further showing that PSA in-
eracts with and induces maturation of DCs. These
indings are consistent with the fact that DCs, not B
ells, mediate intestinal antigen presentation to T cells
fter conventionalization of germ-free animals (Yama-
aka et al., 2003).
SA Induces T Cell Proliferation When
resented by DCs In Vitro
o further investigate cellular and molecular events un-derlying immune responses to PSA, we developed an
Gut Bacterial Molecule Directs Immune Development
111Figure 3. PSA Is Specifically Recognized by DCs in the GI Tract and In Vitro, with Consequent Cell Activation
(A) Oral treatment of mice with Alexa-594-labeled PSA results in antigen uptake by CD11c+ DCs from MLNs. FC of CD11c+ gated cells (boxed
left panel, middle) analyzed for the presence of PSA (horizontal axis of right panels) shows colocalization of PSA with DCs. FC of isolated
MLNs reveals no PSA associated with CD4+ T cells from the same lymph nodes (boxed left panel, bottom). Isotype control is shown in the
top left panel. Gray histograms represent unstained control, and thick black lines denote Alexa-594 signal from PSA on the horizontal axis.
No PSA is detectable in splenic tissues (data not shown).
(B) Confocal microscopy of α-CD11c-labeled (green) and 24 hr PSA-treated (red) BMDCs in culture illustrates antigen in endosomes and
surface display (arrowheads). Central image is the xy plane of a medial z section; upper and side panels are assembled z stacks.
(C) FC of BMDCs cultured for 24 hr with PSA shows activation by upregulation of MHC II (horizontal axis) among CD11c+ cells (vertical axis).
(D) FC of CD11c+ BMDCs cultured for 24 hr with PSA shows activation through upregulation of the costimulatory molecule CD86 (B7.2).in vitro coculture system using primary cells to assess
the ability of purified PSA to induce T cell proliferation
and cytokine expression. As shown above, PSA treat-
ment leads to CD4+ T cell expansion in mice. Incuba-
tion of PSA with CD11c+ BMDCs and naive splenic
CD4+ T cells leads to a dose-dependent increase in T
cell proliferation (Figure 4A). Neutralization of the posi-
tive charge by chemical modification of PSA (N-acet-
ylated [NAc] PSA) results in no incorporation of
[3H]thymidine—a marker for cell replication. This ex-
tends to DCs our observation that the zwitterionic
structure of PSA is critical for biological activity (Kalka-Moll et al., 2002; Tzianabos and Kasper, 2002). Purified
E. coli LPS does not induce T cell proliferation in mice
(Figure 4A; LPS). PSA-mediated CD4+ T cell prolifera-
tion requires both DCs and T cells; either cell type alone
results in no incorporation of radiolabel (Figure 4A). To-
gether, these results show that DCs can direct T cell
proliferation in response to purified PSA in vitro.
PSA Induces T Cell Cytokine Production
in Dendritic-Cell Cocultures
The two subtypes of effector CD4+ T cells, T 1 and T 2,H H
are defined by expression of the cytokines interferon γ
Cell
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Production In Vitro u
(A) CD4+ T cell proliferation by [3H]thymidine incorporation in- m
creases in response to irradiated BMDCs (1 × 106) incubated with C
PSA. Treatment of cocultures with NAc-PSA results in no increase
sin cell proliferation. LPS treatment or DCs or T cells alone do not
ssupport CD4+ T cell proliferation. Results are representative of
1three experiments. Error bars represent the ± SD from triplicate
samples of a single experiment. m
(B) PSA treatment stimulates IFNγ in DC-T cell cocultures, as mea- m
sured by ELISA of culture supernatants after 48 hr of treatment. t
NAc-PSA treatment has no effect. Treatment with α-CD3, LPS, and
iSEA, all known stimulators of TH1 cytokine expression, results in
iIFNγ expression. DCs or T cells alone treated with PSA do not sup-
tport cytokine expression.
(C) PSA treatment does not stimulate expression of IL-4 in DC-T C
cell cocultures. Treatment with α-CD3 and SEA, known stimulators n
of TH2 cytokine expression, results in IL-4 production. s
o
r(IFNγ) and interleukin 4 (IL-4), respectively (Janeway et
al., 2001). As shown above, PSA induces CD4+ T cell t
mexpansion in B. fragilis-colonized mice and in vitro. To
further characterize the effects of PSA-mediated T cell m
mactivation, we assessed cytokine profiles using purified
cellular components. Coculture of DCs and CD4+ T k
dcells in the presence of PSA yields dose-dependent
upexpression of the TH1 cytokine IFNγ (Figure 4B). The t
level of IFNγ production associated with PSA is compa-able to that associated with several known potent IFNγ
nducers (α-CD3, LPS, and staphylococcal enterotoxin
[SEA]) and requires both DCs and T cells (Figure 4B).
pecificity is evidenced by the lack of TH1 cytokine pro-
uction after NAc-PSA treatment (Figure 4B).
TH1 cytokine production suppresses TH2 responses;
onversely, TH2 cytokine expression inhibits TH1 re-
ponses. Normal immune responses require a con-
rolled balance of these opposing signals. Examination
f IL-4 expression in response to PSA treatment reveals
o cytokine production by purified CD4+ T cells (Figure
C; 100 g/ml PSA). α-CD3 and the superantigen SEA
re potent stimulators of both classes of cytokine (Fig-
re 4C). As TH2 cytokine production is a “default path-
ay” in many systems (Kidd, 2003; Amsen et al., 2004)
nd TH1 cytokine production is antagonistic to TH2 ex-
ression, the specific stimulation of IFNγ by PSA in vitro
ay provide a mechanism for establishing commensal-
ediated homeostasis of the host immune system by
alancing TH1/TH2 responses.
H1 Cytokine Production in Response to PSA
reatment Requires Signaling through
he IL-12/Stat4 Pathway and MHC II Expression
unique immunologic molecule, PSA is the only carbo-
ydrate studied to date that is internalized into APCs
nd displayed by MHC II to T cells (Cobb et al., 2004)—
process previously reserved for protein antigens. We
urther characterized the molecular pathway for PSA-
nduced TH1 cytokine production. Many of the molecu-
ar signaling events involving T helper cytokine expres-
ion are well characterized. The major pathway of IFNγ
pregulation and TH1 cell differentiation involves DC
ecretion of IL-12, which binds to the IL-12 receptor on
cells and signals to activate the TH1-specific tran-
cription factor Stat4 (Trinchieri, 2003). PSA stimulation
f DC-T cell cocultures elicits a dose-dependent in-
rease in IL-12 production (Figure 5A). DCs alone stim-
lated with PSA secrete IL-12 (Figure 5A, DC 100 g/
l PSA), although at levels lower than those found for
D4+ T cells. This is the first bacterial polysaccharide
hown to signal IL-12 secretion by APCs, as previously
hown for classical protein antigens (Macatonia et al.,
995). NAc-PSA, lacking the essential positive-charge
otif, does not stimulate cytokine production. To deter-
ine whether IL-12 is required for TH1 cell differentia-
ion, we measured IFNγ expression after PSA treatment
n the presence of increasing concentrations of neutral-
zing antibody to IL-12 (Heufler et al., 1996). IL-12 neu-
ralization abolishes PSA-mediated IFNγ secretion by
D4+ T cells in vitro (Figure 5B). Ablation of IL-12 sig-
aling does not affect α-CD3-mediated IFNγ expres-
ion, as this signal is APC independent, acting directly
n T cells. To determine whether IL-12 signaling that
esults in TH1 lineage differentiation involves the Stat4
ranscription factor, we incubated DCs from wild-type
ice with CD4+ T cells from stat4 knockout mice and
easured IFNγ expression in response to PSA treat-
ent. The absence of Stat4 greatly reduces TH1 cyto-
ine production (Figure 5C); thus, PSA specifically in-
uces DCs to signal T cell differentiation through Stat4
ranscriptional regulation.
To investigate whether antigen presentation of PSA
Gut Bacterial Molecule Directs Immune Development
113Figure 5. PSA Signals through the IL-12/Stat4 Pathway to Mediate TH1 Cytokine Production, which Requires Presentation by MHC II
(A) PSA stimulates expression of IL-12, the TH1 determining signal, in DC-T cell cocultures (1 × 106 of each cell type). NAc-PSA treatment
has no effect. α-CD3 and SEA serve as controls for IL-12 expression by BMDCs. Results are representative of two experiments.
(B) IL-12 is required for PSA-mediated IFNγ production. IFNγ expression is abolished in DC-T cell cocultures treated with PSA (100 g/ml)
in the presence of neutralizing antibody to IL-12. Neutralization of IL-12 does not inhibit α-CD3-mediated IFNγ expression, which is IL-12
independent.
(C) PSA signals through Stat4 to induce IFNγ secretion by T cells. IFNγ expression from DC-T cell cocultures treated with PSA (100 g/ml) is
reduced when CD4+ T cells are purified from spleens of stat4 knockout rather than wild-type mice (Figure 4B).
(D) MHC II expressed on DCs is necessary for PSA-mediated IFNγ expression by CD4+ T cells. IFNγ production by DC-T cell cocultures
treated with PSA (100 g/ml) is reduced when BMDCs are from MHC II knockout mice. NAc-PSA (100 g/ml) treatment of wild-type DCs
(MHC II+/+) serves as the control for PSA-specific IFNγ expression.is required for cytokine signaling, we purified DCs from
MHC II-deficient mice and treated DC-T cell cocultures
with PSA or NAc-PSA. The level of IFNγ expression is
significantly higher in wild-type (MHC II+/+) mice treated
with PSA than in MHC II knockout mice (MHC II−/−),
which express amounts similar to a NAc-PSA control
(Figure 5D). Together, these results demonstrate that
TH1 cytokine responses to PSA require MHC II expres-
sion by APCs and involve signaling through the IL-12/
Stat4 pathway to induce T cell activation and proper
cytokine expression.
PSA Is Required for Appropriate CD4+ T Helper
Cytokine Production during Colonization
A proper TH1/TH2 balance is critical for human and ani-
mal health; over- or underproduction of either response
is associated with immunologic disorders. We investi-
gated the effects of PSA on TH1/TH2 cytokine re-
sponses in colonized animals, again using germ-free
mice. CD4+ T cells from mouse spleens were purified
and tested by ELISA for cytokine production. Figure 6A
shows overproduction of the TH2 cytokine IL-4 in
spleens of germ-free mice compared with levels in con-
ventional mice. This result is consistent with previous
reports of the appreciably TH2-skewed profile of mice
devoid of bacterial contamination and reflects the hu-man neonatal (precolonization) cytokine profile (Kirja-
vainen and Gibson, 1999; Prescott et al., 1998; Adkins,
2000; Kidd, 2003). This “default” TH2 bias in the ab-
sence of bacterial colonization again highlights the
profound contributions of the microflora to immune de-
velopment and provides a model to test the effects of
symbiotic bacteria on the establishment of appropriate
host cytokine production.
Mice colonized with wild-type B. fragilis alone display
a level of IL-4 production similar to that in conventional
mice with a complex microflora (Figure 6A); this sim-
ilarity shows the organism’s sufficiency to correct sys-
temic immune defects. Moreover, mice colonized with
B. fragilis PSA produce TH2 cytokines at elevated
levels similar to those in germ-free mice (Figure 6A).
Thus, the expression of a single bacterial antigen al-
lows B. fragilis to correct the IL-4 cytokine imbalance
found in uncolonized animals.
Examination of IFNγ production by purified splenic
CD4+ T cells reveals that germ-free mice, which are
TH2-skewed, are deficient in production of this proto-
typical TH1 marker when compared to conventional
mice (Figure 6B). Colonization with wild-type B. fragilis
alone is sufficient to correct the defect in IFNγ expres-
sion in germ-free mice, with levels nearly as high as
those in conventional mice (Figure 6B). Lack of PSA
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ogies
(A) IL-4 production from splenic CD4+ T cells stimulated in vitro with α-CD3/α-CD28 (2 g/ml each) reveals that PSA is required to correct
the TH2 skew in GF mice. Compared with CNV mice, GF mice overproduce IL-4 (first and second bars). Intestinal colonization with B. fragilis
(third bar) reduces the expression of IL-4 from levels in GF mice. B. fragilis PSA colonization fails to correct the TH2 skew (fourth bar). Results
are representative of two experiments from pools of four mice. Error bars represent the ± SD from triplicate samples of a single experiment.
(B) IFNγ expression by splenic CD4+ T cells during colonization indicates increased TH1 cytokine production in CNV compared to in GF mice
(first and second bars). PSA production by intestinal B. fragilis is required for the increase in IFNγ expression and immune homeostasis (third
bar); homeostasis is not seen in the absence of PSA (fourth bar). Error bars represent the ± SD from triplicate samples of a single experiment.
(C) Intracellular cytokine staining and FC of in vitro-stimulated (500 ng/ml PMA, 5 g/ml ionomycin) cultures of splenic CD4+ T cells for 4 hr
in the presence of brefeldin A show that IFNγ (horizontal axis) is produced specifically by CD4+ T cells (vertical axis) during bacterial coloniza-
tion. PSA production by B. fragilis is required for the specific increase in IFNγ expression to levels similar to those for CNV mice. GF and
B. fragilis PSA-colonized mice express low levels of TH1 cytokines. Results are representative of three experiments with pools of 3 to 5 mice.
(D) Thymic histology of germ-free mice (H&E) colonized with wild-type or B. fragilis PSA for over 1 year reveals follicles (arrows) within the
inner medullary compartment in the absence of PSA. None of five B. fragilis-colonized compared to 3 of 5 B. fragilis PSA-colonized mice
displayed follicles.
(E) FC of thymic tissues recovered from groups of differentially colonized GF mice (ten per group) reveals the anomalous presence of CD19+
B cells in B. fragilis PSA-colonized mice, a condition likely resulting from increased TH2 cytokine production in the absence of PSA.production by the B. fragilis mutant during colonization d
pof germ-free mice results in low-level production of TH1
cytokines (Figure 6B). These results were corroborated c
tby intracellular cytokine staining of splenic lympho-
cytes from each group, which confirms that IFNγ pro- suction is attributable to CD4+ T cells (Figure 6C). The
roduction of IL-2, another TH1 cytokine, by CD4+ T
ells in gnotobiotic mice also requires PSA produc-
ion (data not shown). Together, these results demon-
trate that intestinal colonization of germ-free mice by
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temic TH1/TH2 balance within the host—a fundamental
aspect of the mammalian immune response.
Absence of PSA Production by B. fragilis during
Colonization Is Associated with TH2-Mediated
Pathologies of the Thymus
Throughout our studies, specimens obtained at nec-
ropsy were subjected to histological examination. We
noticed a rare pathology of the thymus exclusively in
mice colonized with B. fragilis PSA. Thymic tissues
from germ-free mice colonized with wild-type B. fragilis
appear normal, with a darker-staining outer corona and
a uniform and homogeneous inner medullary compart-
ment. Surprisingly, at >1 year of age, the majority of
mice colonized with B. fragilis PSA display the out-
growth of B cell-like follicles in the thymic medulla (Fig-
ure 6D). Flow cytometry shows that these tissues con-
tain CD19+ B cells (Figure 6E) not found in the normal
thymus. This rare condition appears to be similar to hu-
man thymic hyperplasia, in which B cells are found in
follicles of the medulla (Kasper et al., 2005). The latter
condition is associated with numerous autoimmune
disorders, most notably myasthenia gravis, a B cell-
mediated pathology (Malhotra et al., 1992; Infante and
Kraig, 1999). These disorders, as well as B cell out-
growths, are mediated by overproduction of TH2 cyto-
kines by CD4+ T cells (Zhang et al., 1997; Janeway et
al., 2001). It is compelling to speculate that the inability
to restore proper TH1/TH2 balance in germ-free mice
through appropriate commensal colonization results in
an aberrant TH2 response, which may lead to immune-
mediated pathologies.
Discussion
PSA of Intestinal Bacteria as a Symbiosis Factor
The vertebrate brain and immune system are the only
organs that require environmental interactions for de-
velopment. We report here that maturation of the mam-
malian immune system requires the specific direction of
an immunomodulatory molecule provided by symbiotic
bacteria. B. fragilis, a ubiquitous constituent of the mam-
malian lower gastrointestinal microflora, elaborates a
ZPS (PSA) that directs the development of CD4+ T cells;
the eventual result is the correction of immunologic de-
fects found in the absence of bacterial colonization. Im-
paired systemic CD4+ T cell maturation, aberrant TH1/
TH2 lineage differentiation, and defective lymphoid-organ
development are all corrected by PSA production dur-
ing B. fragilis colonization. DCs in GALT apparently
sample B. fragilis and/or PSA from the intestine and,
after activation, migrate to lymphoid organs and signal
TH1 lineage differentiation through the IL-12/Stat4 path-
way. As TH1 cytokine production opposes the TH2 de-
fault phenotype (Kidd, 2003), this process may contrib-
ute to protection from disease by creating appropriate
cytokine balances in the immune system. The estab-
lishment of proper host immunologic function through
responses to PSA identifies this molecule as a factor
required for symbiosis.The Timeless Struggle between Good
and Bad (Bacteria)
The origins of microbiology lie in the study of bacterial
pathogens. Louis Pasteur and Robert Koch were driven
to identify the microbial etiologies underlying infections
(Falkow, 2004). Investigation into pathogens has re-
vealed microbial molecules that mediate aspects of
the infectious process, many of which have been ex-
perimentally identified as virulence factors in animal
models of disease (Monack et al., 2004). Countless mo-
lecular and cellular inflammatory responses to these
molecules are well documented, and the results of
some interactions lead to development of immunologic
memory and resistance to reinfection. This acquired im-
munity reflects the immune system’s ability to recog-
nize and adapt to specific foreign molecules. However,
bacterial infections by pathogens are rare and opportu-
nistic. The vast majority of human encounters with bac-
teria involve harmless organisms found in our environ-
ment or as commensals in our bodies (Hooper and
Gordon, 2001). These are the species with which we
have coevolved. Unlike pathogens, certain commensals
may be beneficial to human development and physiology.
The Gut Reaction to Symbiosis
How is the immunomodulatory signal provided by PSA
in the intestine ultimately transduced to the rest of the
immune system? DCs have received much attention as
mediators of nonclassical T cell responses (Morelli and
Thomson, 2003). Whereas other APCs provide proin-
flammatory instructions during infection, DCs uniquely
signal protective and tolerance-inducing reactions by T
cells (Colonna et al., 2004). This function may underlie
DC positioning at mucosal and epidermal surfaces con-
stantly encountering antigens that may not necessarily
induce inflammation (e.g., antigens associated with
commensal bacteria or food; inhaled antigens). DCs
have evolved various mechanisms for sampling anti-
gens from the gastrointestinal luminal compartment
(Rescigno et al., 2001; Mowat, 2003). Concordantly,
DCs are the APCs that mediate the generation and ac-
tivity of regulatory T cells (Tregs), a CD4+ T cell subset
involved in suppression of immune reactions and direc-
tion of TH1/TH2 responses (Groux et al., 2004; Mills,
2004). We show here that PSA produced by an intesti-
nal symbiont is presented to T cells by DCs, with con-
sequent signaling, immune activation, and cytokine
production. Neither B. fragilis nor PSA is detectable in
spleens of colonized germ-free mice (data not shown),
although we find PSA in MLNs. DCs internalize com-
mensal bacteria in the gut and migrate only as far as
MLNs to mediate immune responses (Macpherson and
Uhr, 2004). As peripheral Tregs are known to traffic to
sites of inflammation where they control T cell reactions
(Kohm et al., 2002; Zou et al., 2004), T cell migration
from lymph nodes to spleen may mediate the cellu-
lar signal-transduction mechanisms required for PSA-
mediated immune development at extraintestinal sites.
Are Bacterial Symbionts the Victims
of Good Hygiene?
In 1989, it was postulated that reduced exposure to in-
fectious bacterial agents early in life due to improved
Cell
116fsanitation and antibiotic use explained increases in
Sallergy among residents of industrialized countries, a
concept termed the hygiene hypothesis (Strachan, 1989).
h
In a proposed modified counterregulation model, im- w
proved hygiene limits exposure to immunomodulatory f
emolecules of beneficial commensal bacteria that pro-
(vide protection from unrelated immune diseases (Wills-
Karp et al., 2001). Substantial evidence from the past
40 years indicates that incidences of atopy (allergy pre- L
disposition) and asthma have increased dramatically in L
Western nations but not in developing countries. Sev- b
peral epidemiologic studies indicate that atopic and
gnonatopic people differ in gut flora composition (Bjork-
dsten et al., 1999; Kirjavainen et al., 2001; Kalliomaki et
al., 2001). Thus, hygiene-associated deviations in gut
microflora composition may be the environmental factor F
underlying development of atopy and asthma in geneti- a
Dcally predisposed individuals.
u“Does the microbiota regulate immune responses
loutside the gut?” (Noverr and Huffnagle, 2004). Asthma
2
and allergies are nonintestinal immunologic disorders w
mediated by overproduction of TH2 cytokines and of k
IgE—also a component of the TH2 response (Umetsu b
bet al., 2002). Here we show that colonization with the
3ubiquitous commensal B. fragilis corrects the systemic
CTH2 bias found in the absence of bacterial colonization w
through specific production of TH1 cytokines. Systemic F
expression of IFNγ, the characteristic TH1 marker, inhib- w
its TH2 cytokine reactions and reduces IgE production
(Kidd, 2003), providing a mechanism for establishment
Pof immunologic cytokine balance. Germ-free mice and
Patopic patients with altered gut microflora have a highly
1
TH2-skewed cytokine profile (Shi and Walker, 2004). n
Colonization of germ-free mice with PSA-producing 1
PB. fragilis restores normal cytokine production. Probi-
wotic studies with Lactococcus and Bifidobacterium
tspecies suggest that other prominent gut bacteria may
walso produce immunomodulatory molecules (Guarner
and Malagelada, 2003; Rastall, 2004). Perhaps perva-
sive antibiotic use among children in industrialized I
Fcountries leads to clearance of symbionts such as B. frag-
ailis at an essential point in immune development and
(results in the absence of molecules with PSA-like activ-
T
ities. Aberrant immune development without specific 3
direction by this class of immunomodulatory molecules α
may lead to a default pathway of TH2 cytokine overpro- s
duction and the onset of atopic and asthmatic disor-
cders. Future investigations must determine the function
>of immunomodulatory molecules of symbiotic bacteria
t
in the critical balance between mammalian health and C
disease. C
i
Experimental Procedures
a
Mice and Bacterial Strains a
Conventional SPF mice of strains C57BL/6NTac, BALB/cAnNTac, w
B6.SJL-Ptprca/BoAiTac-H2-Ab1tm1GLM N13 (MHC II−/−), and B6.SJL- h
Ptprca/BoAiTac (MHC II−/− control) were purchased from Taconic E
Farms (Germantown, New York). C.129S2-Stat4tm1Gru (Stat4−/−) mice c
were purchased from Jackson Laboratory (Bar Harbor, Maine). These
mice were housed in conventional cages at Harvard Medical
School. Germ-free Swiss-Webster mice were from Taconic Farms H
Pand were housed in sterile isolators (Class Biologically Clean, Mad-
ison, Wisconsin). Mice were screened weekly for bacterial, viral, w
Band fungal contamination. All procedures with mice were per-ormed according to guidelines of the HMS Office for Research
ubject Protection.
B. fragilis strain NCTC 9343 and its isogenic PSA deletion mutant
ave been described (Coyne et al., 2001). For mouse colonization,
1 × 108 cfu of bacteria grown in BHI medium were spread on
ood and bedding. Mice were colonized for at least 60 days before
xamination. Results are for mice up to 8 months postcolonization
except thymic pathology, which requires aging over 1 year).
ymphocyte Isolation from Tissues
ymphocytes were isolated from tissues (Tzianabos et al., 2000). In
rief, spleens, thymus, and MLNs were disrupted into single-cell
reparations and enriched for lymphocytes over a Histopaque 1083
radient (Sigma, St. Louis). Cells were washed with PBS and used
irectly or fixed with 0.5% PFA for 1 hr at 4°C.
low Cytometry, Fluorescence-Activated Cell Sorting,
nd Intracellular Cytokine Staining
irectly fluorochrome-conjugated monoclonal antibodies were
sed (BD Pharmingen, San Diego, California). For surface staining,
ymphocyte preparations were washed twice in FC buffer (PBS with
% FBS) and resuspended in 100 l. 1 × 106 cells were incubated
ith antibodies at 2 g/ml for 30 min at 4°C. For intracellular cyto-
ine staining, cells were resuspended in 100 l of Cytofix/Cytoperm
uffer for 30 min at 4°C, washed with Perm/Wash buffer, and incu-
ated with fluorochrome-conjugated anti-cytokine antibodies for
0 min at 4°C. Cells were washed and analyzed on a model FC500
ytometer (Beckman Coulter, Fullerton, California), and all data
ere analyzed with RXP Analysis Software (Beckman Coulter).
ACS was performed on a BD FACSAria, and cell purity was al-
ays >99%.
SA Purification and Animal Treatment
SA from B. fragilis NCTC 9343 was prepared (Tzianabos et al.,
992). For some studies, PSA was treated with acetic anhydride to
eutralize the positively charged amino group (Tzianabos et al.,
994). Mice received 50 g of PSA in 1.5% sodium bicarbonate/
BS intraperitoneally or intragastrically three times a week for 2
eeks. Rag2−/− mice received 30 g of PSA (PBS controls) in al-
ernating intragastric and subcutaneous treatments three times a
eek.
n Vitro Cytokine Stimulation and Proliferation Assays
or analysis of splenic cytokines, lymphocytes were isolated as
bove. CD4+ T cells were purified with the MACS CD4 Sorting Kit
Miltenyi Biotec, Auburn, California). Cell purity was >97% CD4+.
he remaining lymphocytes were used as APCs after γ irradiation.
× 105 cells of each type were mixed in a 48-well plate, and
-CD3/α-CD28 (2 g/ml) was added. Supernatants recovered after
timulation for 48 and 72 hr were analyzed by ELISA.
For cocultures, CD4+ T cells were purified from splenic lympho-
ytes with a CD4+ T Cell Subset Kit (R&D Systems). Cell purity was
95%. BMDCs from femurs of mice were purified. Cells were cul-
ured for 8 days in C-RPMI-10 with GM-CSF (20 ng/ml; Biosource,
amarillo, California). Cells were >90% CD11c+. 1 × 106 purified
D4+ T cells were mixed with 1 × 106 purified CD11c+ BMDCs and
ncubated at 37°C/5% CO2.
ELISA plates were from precoated kits (Biosource). T cell prolifer-
tion assays were done with 1 × 105 cells of each type (APCs irradi-
ted) after incubation for 96 hr. For the last 8 hr before harvest,
ells were pulsed with [3H]thymidine (1 Ci/well). Cells were washed,
arvested, and counted by liquid scintillation (Wallac; now Perkin-
lmer, Boston). Data were expressed as mean cpm ± SD for tripli-
ate wells.
istological Tissue Analysis
araffin-embedded mouse tissues were stained with H&E. Sections
ere evaluated in blinded fashion by a single pathologist (R.T.
ronson, HMS).
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